E‐cadherin plays a major role in cell–cell adhesion and inactivating germline mutations in its encoding gene predispose to hereditary diffuse gastric cancer. Evidence indicates that aside from its recognized role in early tumourigenesis, E‐cadherin is also pivotal for tumour progression, including invasion and metastization. Herein, we discuss E‐cadherin alterations found in a cancer context, associated cellular effects and signalling pathways, and we raise new key questions that will impact in the management of GC patients and families.
E‐cadherin dysfunction in gastric cancer ‐ Cellular consequences, clinical applications and open questions
Patrícia Carneiro,Maria Sofia Fernandes,J. Figueiredo,J. Caldeira,J. Carvalho,H. Pinheiro,Marina Leite,Soraia Melo,P. Oliveira,J. Simões-Correia,M. Oliveira,F. Carneiro,C. Figueiredo,J. Paredes,Carla Oliveira,R. Seruca
Published 2012 in FEBS Letters
ABSTRACT
PUBLICATION RECORD
- Publication year
2012
- Venue
FEBS Letters
- Publication date
2012-08-31
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-100 of 100 citing papers · Page 1 of 1